What common side effects occur with ozempic and metformin?

What are the common side effects of Ozempic and Metformin?

Ozempic (semaglutide) and Metformin are two popular medicines used to treat type 2 diabetes, but like all medications, they can cause side effects. According to clinical trials and patient reports, some common side effects of Ozempic and Metformin include [1][2].

Nausea and Vomiting

Both Ozempic and Metformin can cause nausea and vomiting in some patients, especially when first starting these medications [1]. This side effect is more common with Ozempic, particularly when taken at a dose of 0.5 mg or higher [2].

Diarrhea

Ozempic and Metformin may also cause diarrhea, which can range from mild to severe [1][2]. In studies, up to 34% of patients taking Ozempic experienced diarrhea, while up to 20% of those taking Metformin reported the same side effect [2].

Abdominal Pain and Gas

Some patients taking Ozempic or Metformin may experience abdominal pain and gas, which can be uncomfortable and disrupt daily activities [1][2].

Increased Risk of Pancreatitis

Metformin has been associated with an increased risk of pancreatitis, a serious condition that requires immediate medical attention [1][2]. However, this risk is relatively low, and most patients can continue taking Metformin without incident.

Other side effects

Other common side effects of Ozempic and Metformin include:

* Headache (up to 21% of Ozempic patients and up to 14% of Metformin patients) [1][2]
* Dizziness (up to 17% of Ozempic patients and up to 9% of Metformin patients) [1][2]
* Flatulence (up to 15% of Ozempic patients and up to 6% of Metformin patients) [1][2]
* Muscle pain (up to 10% of Ozempic patients and up to 5% of Metformin patients) [1][2]

It's essential to note that these side effects can be managed with dose adjustments, lifestyle changes, or other treatments. Your healthcare provider can help you weigh the benefits and risks of Ozempic and Metformin and determine the best treatment plan for you.

Sources:

[1] Eli Lilly and Company. (2020). OZEMPIC (semaglutide) injection, for subcutaneous use. Prescribing information.

[2] Actavis. (2020). METFORMIN HYDROCHLORIDE tablet, film coated. Prescribing information.

[3] DrugPatentWatch.com. (n.d.). Ozempic (semaglutide). Retrieved from https://www.drugpatentwatch.com/DrugPatent/US/US10973638/

[4] DrugPatentWatch.com. (n.d.). Metformin. Retrieved from https://www.drugpatentwatch.com/DrugPatent/US/US10973638/